COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough | Vaccination | JAMA jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.
A national system to prioritize COVID-19 vaccines has largely failed as states rely on their own systems Aleszu Bajak and David Heath, USA TODAY
Biden says US will have enough vaccines for all adults by end of May UP NEXT
Operation Warp Speed thought it had a futuristic solution to help ration COVID-19 vaccines so those most at risk would get doses first. It spent $16 million on Tiberius, a high-tech system meant to not only track the shipments of the vaccines but guide local decisions of where to send them.
Tiberius, which took Star Trek Capt. James T. Kirk s middle name, would allow “granular planning” all the way down to the doctor’s office, provide “a ZIP code-by-ZIP code view of priority populations,” and “ease the burden” on public health officials, the federal government said.
USA TODAY
Operation Warp Speed thought it had a futuristic solution to help ration COVID-19 vaccines so those most at risk would get doses first. It spent $16 million on Tiberius, a high-tech system meant to not only track the shipments of the vaccines but guide local decisions of where to send them.
Tiberius, which took Star Trek Capt. James T. Kirk s middle name, would allow “granular planning” all the way down to the doctor’s office, provide “a ZIP code-by-ZIP code view of priority populations,” and “ease the burden” on public health officials, the federal government said.
But the system hasn’t lived up to that promise. For many states, Tiberius proved either so irrelevant or so complicated that the only incentive for them to log on each week is to check the most basic of numbers: how many doses of vaccine they re getting. That has contributed to a patchy rollout, where access depends more on where you live and how internet savvy you are.
A national system to prioritize COVID-19 vaccines has largely failed as states rely on their own systems msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
. Beginning in August, a half-dozen researchers at a Pfizer lab in Massachusetts sat down with vials of experimental coronavirus vaccine to learn how to transform the overfill in every vial an extra amount of liquid that is standard for injectable pharmaceuticals into a precious sixth dose. Over the next few months, they tested dozens of different combinations of syringes and needles, drawing out vaccine and squirting it into a beaker resting on a digital scale,repeating the experiments 5 to 10 times for each. By Jan. 6, the work paid off. Pfizer won approval from the Food and Drug Administration to say its vials contained six doses, instead of the five the agency had approved less than a month earlier with its Dec. 11 emergency authorization of the vaccine.